Cervantes Corp Ltd

Alexander Saint-Amand founded Topography Health to simplify clinical research for physicians and improve patient access. 95% of physicians quit research by their third study due to administrative burdens. Topography supports physicians with administrative tasks, restoring their love for medicine and making patients 'over the moon happy'. The clinical trial business is distinct from hospital operations, lacking a revenue cycle platform as it doesn't involve payers. Topography integrates all business elements to support research, taking full risk through shared profits in research programs.

Ascension disclosed a cyberattack affecting 5.6M patients and staff, Gilead will halt free HIV drug access, Ionis won FDA approval for a rare disease drug, a new health clinic aims to reduce barriers in Denver, and Amazon settled worker safety citations for $145,000.

Ohio Board of Pharmacy launched a tool aiding low-vision, hearing-impaired, and non-English speaking individuals in finding accessible pharmacies, amidst pharmacy closures driven by low reimbursements and fees.

The Biden administration proposed a rule allowing Medicare and Medicaid to cover weight loss drugs for patients with obesity, potentially costing $40 billion over a decade. This move aims to address the chronic nature of obesity, which affects over 40% of Americans and is expected to reach 50% by 2030. The proposal, if approved by the incoming Trump administration, would expand access to GLP-1 drugs like Wegovy and Zepbound, which have shown efficacy in weight loss, but are currently expensive and covered by few insurance plans. The rule would benefit drugmakers and chronic care management companies, but its fate depends on the incoming administration's stance on GLP-1s.

CVS Health's Mike Pykosz departs, replaced by Dr. Sreekanth Chaguturu; Neuralink to begin Canadian clinical trial for brain-computer interface; VA's omnibus bill omits Oracle EHR oversight measures; 23andMe partners with Mirador Therapeutics for research.

Walgreens plans to close 1,200 stores over 3 years, focusing on its retail pharmacy-led legacy. Despite operating losses, its clinical trials business remains unaffected, with ongoing partnerships and recruitment efforts targeting diverse populations.

Walgreens plans to close 1,200 stores over three years due to $3 billion loss, focusing on its retail pharmacy legacy. Despite this, its clinical trials business remains unaffected, with ongoing partnerships and recruitment efforts targeting diverse populations.

SneakPeek®, the first at-home early fetal sex test for use at six weeks, is now available at over 8,800 retail locations nationwide, including Walmart, Walgreens, and CVS. The test, with over 99% accuracy, is the #1 OBGYN-recommended gender test, offering expectant parents the ability to learn their baby's sex as early as six weeks into pregnancy.